Published in Cancer Weekly, February 27th, 2001
"Basic fibroblast growth factor (FGF-2) is an important stimulator of angiogenesis that has been implicated in neoplastic progression," wrote S.M. Plum and colleagues of EntreMed Inc., Rockville, Maryland. "Attempts to neutralize or modulate FGF-2 have met with some success in controlling neovascularity and tumor growth."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.